Color Health said on Friday that it has partnered with the US Centers for Disease Control and Prevention to increase access to no-cost, PCR-based, COVID-19 testing.
Quest Diagnostics said Thursday that it is participating in the Centers for Disease Control and Prevention's (CDC) Increasing Community Access to Testing (ICATT) for COVID-19 program.
Recently, Wuhan YZY Biopharma Co., Ltd completed a 200 million CNY Pre-C round of financing. This round of financing was completed by the joint investment of Wuhan Hi-Tech, Hubei Science Technology Investment and Optics Valley Financial Holding Group.
The FDA cautioned in late 2021 after the omicron variant emerged that antigen tests may have reduced sensitivity, meaning they correctly identify fewer people with COVID-19. Data have continued to accumulate that the tests are not as sensitive to the newer variants of the virus, Stenzel said.
Although Covid-19 is not over yet, the market conditions of nucleic acid and antigen detection reagents are rapidly cooling down, and even "cliff-like" subsidence.
Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over. A key challenge in limiting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is identifying infected individuals.
FDA issued a recommendation on June 30, 2022 to COVID-19 vaccine manufacturers that indicated that they should include an Omicron subvariant BA.4/5 component in their vaccines.
PreventionGenetics said Thursday that it has been granted marketing authorization for its POMC/PCSK1/LEPR companion diagnostic as a Class II device by the US Food and Drug Administration.
Becton Dickinson has obtained the CE-IVD mark on a combined panel assay to detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus. The assay runs on the firm's BD Max instrument and is now available in countries that recognize the CE mark, the firm said on Thursday.
On June 28, the National Health Commission of the PRC released the "COVID-19 Prevention and Control Plan (Ninth Edition)". Compared with the eighth edition, the following revisions were made:
✔ All (413)
✔ Press release (3)
✔ Industry news (410)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.